Sagimet Biosciences Inc. Quarterly Operating Lease, Liability in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Sagimet Biosciences Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2022 to Q4 2023.
  • Sagimet Biosciences Inc. Operating Lease, Liability for the quarter ending December 31, 2023 was $65K, a 69.2% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $65K -$146K -69.2% Dec 31, 2023 10-K 2024-03-25
Q3 2023 $103K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $140K Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $211K Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.